Healing
Video
The importance of diversity in clinical trials for hepatitis C
Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.
Video
Patient perspectives: understanding healthcare equity as a provider, patient, or person of color
From representation reflected in specialties of medical professionals, to balance within clinical trials, health equity is an ongoing evolution.
Video
How blood transfusions for sickle cell may have impacted hepatitis C rates among Black Americans
In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.
Video
My story: my hepatitis C journey as a Black American
Pat, a hepatitis c survivor, shares her thoughts on disparity within the healthcare system.
Overview
Article
Why hepatitis C is called a "quiet killer"
Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.
Symptoms & Treatment
Article
Who is at risk for hepatitis C?
Learn who has higher odds of contracting this viral infection.